A $7-billion program to help pay for dementia research and therapies in Canada
More than $7.7-million will be paid to patients and their families to assist them with cognitive-related medical expenses, as the Harper government aims to improve care for people with dementia in Canada, a new report says.
The government will commit $500 million to create a national research and clinical infrastructure for brain-health research that will focus on helping people manage their mental health better.
The announcement on Tuesday followed consultations with provincial, territorial and municipal governments, and the Canadian Federation of Independent Business, which represents nearly 2,000 members.
The Canadian Foundation for Health Research will make a $100-million grant to help fund brain-mapping research.
The National Institute for Health Innovation is funding $150 million to further develop and commercialize brain-related products and services.
The Canada Neurological Disease Foundation, which oversees the federal research budget, announced Tuesday that it will create a $6-million provincial brain-research fund.
It will invest $1 million to support research that improves diagnostic technologies for diagnosis and treatment of neurodegenerative diseases such as dementia, Parkinson’s disease and Alzheimer’s disease.
The initiative is part of the government’s $20 billion strategic and strategic development initiative aimed at developing innovative and innovative treatments to prevent, treat and prevent dementia, as well as promoting access to appropriate care.
The new fund also will invest in additional research.
The announcement comes two days after the government launched a $1.4-billion, 10-year, $500-million Alzheimer’s research initiative.
The federal program has already generated $4.8-billion in research awards for dementia patients and families.
In 2018, $5.1-billion worth of grants went to Canadian patients and caregivers, with more than $800 million going to caregivers in the first four months of the year.
Citing recent research, CBC News reported that about 6 per cent of the world’s population of people with severe dementia and Alzheimers has experienced dementia and another 12 per cent had mild symptoms.